MO

Business Context and Reporting Period

This Form 10-Q is a quarterly report for Philip Morris Companies Inc. (Note: The request metadata listed "Altria Group," but the filing text identifies the registrant as Philip Morris Companies Inc., the predecessor to Altria). The report covers the quarterly period ended September 30, 1995, and the nine-month period ended on the same date. The company operates primarily in consumer products (Tobacco, Food, Beer) and Financial Services and Real Estate.

Key Financial Metrics

Debt to Equity Ratio (Consumer Products): 1.10 (down from 1.17 at Dec 31, 1994).

Material Changes vs. Prior Period

• Revenue Growth: Operating revenues increased 3.5% ($1.7 billion) for the nine months ended September 30, 1995. Excluding divested food businesses, revenue growth was 9.4%.
• Profitability: Operating income increased 11.3% ($825 million). Net earnings rose 15.0% to $4.178 billion.
• Tobacco Segment:
  • Domestic: Revenues up 2.1% driven by price increases and mix; volume remained flat while industry volume declined 2.6%. Market share increased to 45.8%.
  • International: Revenues up 20.1% and operating income up 19.6%, driven by volume growth (13.7%), price increases, and favorable currency movements.
• Food Segment: Revenues decreased 4.9% primarily due to divestitures (Kraft Foodservice distribution, specialty oils, marshmallow/caramels). Excluding divestitures, revenues increased 4.1%.
• Beer Segment: Revenues increased 0.7%; operating income increased 8.2% due to price/mix improvements and lower costs.
• Financial Services: Operating income decreased 25.0% due to the timing of residual gains from leveraged leases and the absence of gains from the sale of marketable securities recognized in 1994.

Guidance, Outlook, and Risks

• Regulatory Risks: The FDA initiated a rule-making proceeding asserting jurisdiction over nicotine as a "drug" and cigarettes as a "device," proposing severe restrictions on marketing and distribution. The company is challenging this in court. Additionally, state-level Medicaid reimbursement lawsuits are pending in Florida, Mississippi, Minnesota, and West Virginia.
• Litigation: Significant class action litigation continues regarding smoking and health, including environmental tobacco smoke (ETS) and nicotine addiction. The company also faces shareholder class actions regarding securities laws and inventory management practices.
• Divestitures: The company continues to divest non-strategic food businesses. Subsequent to the quarter, bakery and margarine businesses were sold for approximately $1.0 billion. Further asset write-downs or facility closures may occur in the fourth quarter.
• Capital Allocation: The company increased its quarterly dividend to $1.00 per share (annualized $4.00). It continues a $6 billion stock repurchase program, having spent $1.9 billion through September 30, 1995.
• Accounting Changes: Adoption of SFAS No. 106 (Postretirement Benefits) and SFAS No. 116 (Contributions) resulted in a cumulative effect charge of $28 million to net earnings in the first nine months of 1995.

Investor Verification Checklist

• FDA Jurisdiction: Monitor the outcome of the litigation challenging the FDA's authority to regulate tobacco products as drugs/devices.
• State Medicaid Lawsuits: Track the status of class certification and standing rulings in Florida, Mississippi, Minnesota, and West Virginia, as unfavorable outcomes could lead to significant liability.
• Food Divestitures: Verify the final financial impact of the bakery and margarine sales and any potential asset write-downs announced for the fourth quarter.
• Stock Repurchase Program: Confirm the remaining balance of the $6 billion authorization and the pace of future buybacks.
• International Currency: Assess the sustainability of revenue growth in international tobacco markets, which was significantly aided by favorable currency movements in 1995.